Skip to Content

Join the 'Carimune' group to help and get support from people like you.

Carimune News

Densensitization Procedure Helps Hard-to-Match Kidney Recipients

Posted 27 Jul 2011 by Drugs.com

WEDNESDAY, July 27 – A combination therapy that "desensitizes" kidney transplant recipients could help hard-to-match patients find a needed kidney faster. The desensitization procedure combines the use of plasmapheresis – a machine that filters the blood plasma to remove antibodies – and low-doses of a medication called intravenous immune globulin (IVIG). The combination of these therapies improves survival rates dramatically. Eight years after receiving a transplant, survival rates were 81 percent for those who received the treatment compared to just 31 percent for people who had to stay on dialysis, new research found. "This is a huge unmet problem. There are probably as many as 30,000 people who have been exposed to foreign tissue waiting for a kidney. They're really hard to match," explained study author Dr. Robert Montgomery, director of the comprehensive transplant program at ... Read more

Related support groups: Renal Transplant, Gammagard, Gamunex, Privigen, Immune Globulin Intravenous, Sandoglobulin, Carimune, Venoglobulin-S 5%, Flebogamma, Octagam, Gamimune N 10%, Panglobulin NF, Gammar-P IV, Venoglobulin-S 10%, Carimune NF, Iveegam En, Gamimune, Panglobulin, Gammaplex, Gamimune N 5%

New Alzheimer's Treatment Could Be on the Horizon

Posted 20 Jul 2009 by Drugs.com

MONDAY, July 20 – A treatment already used to bolster the immune systems of people with leukemia and other serious diseases might also help ward off Alzheimer's disease, new research suggests. Researchers looked at the association between the use of intravenous immunoglobulin (IVIg) and the occurrence of Alzheimer's. "IVIg has been used safely for more than 20 years to treat other diseases but is thought to have an indirect effect on Alzheimer's disease by targeting beta-amyloid, or plaques, in the brain," said Dr. Howard Fillit, a clinical professor of geriatrics and medicine at Mount Sinai Medical Center in New York City and the study's lead author. To assess the effectiveness of IVIg against Alzheimer's disease, researchers analyzed the medical records of 847 people ages 65 and older who'd had at least one IVIg treatment at some point in their life and 84,700 people of the same age ... Read more

Related support groups: Alzheimer's Disease, Carimune

Ask a Question

Further Information

Related Condition Support Groups

Chronic Lymphocytic Leukemia (CLL), Idiopathic (Immune) Thrombocytopenic Purpura, Autoimmune Neutropenia, Bone Marrow Transplantation, Primary Immunodeficiency Syndrome, Evan's Syndrome, Kawasaki Disease, HIV Infection, Polymyositis / Dermatomyositis

Carimune Patient Information at Drugs.com